Eteri Natelauri, Medical Director (Chief Medical Officer) & Head of Radiation Oncology Department at VIAN – Krystyna Kiel Oncology Center, and ASTRO Ambassador for Georgia, shared a post by Conveners, on LinkedIn, adding:
“An excellent upcoming educational event: Best of 3rd ASTRO Gulf 2026, an officially licensed ASTRO program bringing high-quality oncology education to the region.
The meeting will cover key updates in radiation oncology and clinical trials, with expert-led discussions and practical insights relevant to daily practice.
Many thanks to the organizers and supporting societies for their efforts in delivering such an important educational platform.
Colleagues in the region — you are warmly invited to attend and take part in the discussions.
Venue: Anatra Downtown Hotel, Dubai
Date: Saturday, 31st January
Register here
CME Hours from DHA
Endorsed by: Emirates Oncology Society| Managed by Conveners.”
Quoting Conveners‘s post:
“Meet Our Expert at Best of 3rd ASTRO Gulf 2026.
We are honored to welcome Dr Eter Natelauri, Radiation Oncologist & Head of Unit C, Department of Radiation Oncology – Kuwait Cancer Control Center.
Dr Natelauri, will share expert insights on:
Phase 3 Study of Pembrolizumab (Pembro) + Adjuvant Chemotherapy (CT) ± Radiotherapy (RT) for Newly Diagnosed, High-Risk Endometrial Cancer (EC): Exploratory Analysis of Disease-Specific–Free Survival (DSFS) and Safety by Radiation Usage
Venue: Anatra Downtown Hotel, Dubai
Date: Saturday, 31st January
Register here
CME Hours from DHA
Endorsed by: Emirates Oncology Society| Managed by 𝗖𝗼𝗻𝘃𝗲𝗻𝗲𝗿𝘀”
More posts featuring Eteri Natelauri.